Baillie Gifford acquired 18M Royalty Pharma plc shares worth $665M. That's 0.48% of their equity portfolio (39th largest holding). The investor owns 4.28% of the outstanding Royalty Pharma plc stock. The first Royalty Pharma plc trade was made in Q1 2022. Since then Baillie Gifford bought shares three more times and sold shares on ten occasions. The investor's estimated purchase price is $706M, resulting in a loss of 5.8%.